ZA77157B - Prostaglandin analogs - Google Patents
Prostaglandin analogsInfo
- Publication number
- ZA77157B ZA77157B ZA770157A ZA77157A ZA77157B ZA 77157 B ZA77157 B ZA 77157B ZA 770157 A ZA770157 A ZA 770157A ZA 77157 A ZA77157 A ZA 77157A ZA 77157 B ZA77157 B ZA 77157B
- Authority
- ZA
- South Africa
- Prior art keywords
- prostaglandin analogs
- prostaglandin
- analogs
- Prior art date
Links
- 150000003180 prostaglandins Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/657,739 US4029681A (en) | 1976-02-13 | 1976-02-13 | 13,14-Didehydro-PG analogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA77157B true ZA77157B (en) | 1977-11-30 |
Family
ID=24638478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA770157A ZA77157B (en) | 1976-02-13 | 1977-01-12 | Prostaglandin analogs |
Country Status (8)
| Country | Link |
|---|---|
| US (10) | US4029681A (ja) |
| JP (1) | JPS52100446A (ja) |
| AU (1) | AU514849B2 (ja) |
| BE (1) | BE851359A (ja) |
| CH (1) | CH628028A5 (ja) |
| DE (1) | DE2704933A1 (ja) |
| NL (1) | NL7701467A (ja) |
| ZA (1) | ZA77157B (ja) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4312810A (en) * | 1978-11-22 | 1982-01-26 | The Upjohn Company | 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds |
| US4294993A (en) * | 1980-04-14 | 1981-10-13 | General Electric Company | Purification of bisphenol-A |
| DE3320260A1 (de) * | 1983-06-04 | 1984-12-06 | Bayer Ag, 5090 Leverkusen | Diphenolmonoester von carbonsaeuren, ein verfahren zu ihrer herstellung, ihre verwendung zur herstellung von polyestercarbonaten, die erfindungsgemaess erhaeltlichen polyestercarbonate sowie flammwidrige formmassen enthaltend diese polyestercarbonate |
| US4576962A (en) * | 1983-10-19 | 1986-03-18 | The Procter & Gamble Company | Prostaglandin analogues |
| CA1241324A (en) | 1984-03-08 | 1988-08-30 | Paul A. Aristoff | Interphenylene carbacyclin derivatives |
| US4822819A (en) * | 1986-11-07 | 1989-04-18 | Alcon Laboratories, Inc. | Use of trimoprostil and derivatives in glaucoma therapy |
| US4822820A (en) * | 1986-11-24 | 1989-04-18 | Alcon Laboratories, Inc. | Use of tri-methyl PG-F2 a and derivatives in glaucoma therapy |
| US5565492A (en) * | 1988-07-18 | 1996-10-15 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| US5173507A (en) * | 1988-07-18 | 1992-12-22 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| EP0591532A4 (en) * | 1991-04-22 | 1994-11-09 | Taisho Pharmaceutical Co Ltd | PROSTAGLANDIN E1 ANALOG. |
| FR2688634B1 (fr) * | 1992-03-10 | 1994-06-03 | Souriau & Cie | Connecteur de type polygonal, notamment rectangulaire a corps central isolant. |
| EP0664707B1 (en) * | 1992-10-13 | 1997-06-04 | Alcon Laboratories, Inc. | Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma |
| WO1994008959A1 (en) * | 1992-10-20 | 1994-04-28 | Taisho Pharmaceutical Co., Ltd. | Prostaglandine derivative |
| CA2147461A1 (en) * | 1992-10-21 | 1994-04-28 | Takehiro Amano | Prostaglandin e1 analogues |
| AU6513294A (en) * | 1993-05-26 | 1994-12-20 | Taisho Pharmaceutical Co., Ltd. | Prostaglandin e1 analog |
| US6294563B1 (en) | 1994-10-27 | 2001-09-25 | Allergan Sales, Inc. | Combinations of prostaglandins and brimonidine or derivatives thereof |
| AU7680096A (en) * | 1995-12-22 | 1997-07-17 | Alcon Laboratories, Inc. | Combinations of dp and fp type prostaglandins for lowering iop |
| US5599838A (en) * | 1996-02-23 | 1997-02-04 | Taisho Pharmaceutical Co., Ltd. | Prostaglandin derivatives |
| WO2000061550A1 (fr) | 1999-04-09 | 2000-10-19 | Taisho Pharmaceutical Co., Ltd. | Derives de prostaglandine e1 |
| EP1219600A4 (en) | 1999-08-13 | 2004-11-03 | Taisho Pharmaceutical Co Ltd | PROSTAGLANDIN DERIVATIVES |
| CA2384148A1 (en) | 1999-09-06 | 2001-03-15 | Taisho Pharmaceutical Co., Ltd. | Prostaglandin e analogues |
| AU766900B2 (en) | 1999-09-10 | 2003-10-23 | Fumie Sato | Prostaglandin derivatives |
| US6740772B1 (en) | 1999-09-10 | 2004-05-25 | Taisho Pharmaceutical Co., Ltd. | Prostaglandin derivatives |
| EP1598335A4 (en) * | 2003-02-20 | 2006-04-12 | Taisho Pharmaceutical Co Ltd | PROSTAGLANDINE DERIVATIVES |
| US8197231B2 (en) | 2005-07-13 | 2012-06-12 | Purity Solutions Llc | Diaphragm pump and related methods |
| US9610392B2 (en) | 2012-06-08 | 2017-04-04 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
| CN116120268A (zh) * | 2023-03-06 | 2023-05-16 | 南京华威医药科技集团有限公司 | 一种他氟前列素中间体杂质及其制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3959346A (en) * | 1969-03-14 | 1976-05-25 | The Upjohn Company | Racemic prostaglandins of the 2-series and analogs thereof |
| US3931411A (en) * | 1971-06-09 | 1976-01-06 | G. D. Searle & Co. | Method for tranquilization without general depression |
| GB1425962A (en) * | 1972-04-13 | 1976-02-25 | Erba Carlo Spa | Lactols and lactones |
| DE2317019A1 (de) * | 1972-04-27 | 1973-11-08 | Upjohn Co | Neue 4,5-didehydro-prostaglandine |
| US3933899A (en) * | 1972-10-30 | 1976-01-20 | The Upjohn Company | PGE2 -oxa-phenylene compounds |
| US3944595A (en) * | 1972-10-30 | 1976-03-16 | The Upjohn Company | PGF1.sub.α -oxaphenylene compounds |
| US3914282A (en) * | 1973-01-16 | 1975-10-21 | Upjohn Co | Prostaglandin E{HD 1{B , F{HD 1{B , and A{HD 1 {B analogs |
| US3962293A (en) * | 1973-07-20 | 1976-06-08 | The Upjohn Company | 13,14-Dihydro-16-fluoro prostaglandin F1 |
| US3980694A (en) * | 1974-04-11 | 1976-09-14 | The Upjohn Company | 4-Oxa phenyl-substituted PGA compounds |
| US3932463A (en) * | 1974-06-03 | 1976-01-13 | American Cyanamid Company | 11-Deoxy-13-dihydro-prostaglandin-9-ketals |
| GB1482047A (en) * | 1974-07-12 | 1977-08-03 | Upjohn Co | Bicyclohexane derivatives for use in the synthesis of prostaglandins |
-
1976
- 1976-02-13 US US05/657,739 patent/US4029681A/en not_active Expired - Lifetime
-
1977
- 1977-01-12 ZA ZA770157A patent/ZA77157B/xx unknown
- 1977-01-14 AU AU21338/77A patent/AU514849B2/en not_active Expired
- 1977-01-27 CH CH102477A patent/CH628028A5/de not_active IP Right Cessation
- 1977-02-07 DE DE19772704933 patent/DE2704933A1/de not_active Withdrawn
- 1977-02-11 NL NL7701467A patent/NL7701467A/xx not_active Application Discontinuation
- 1977-02-11 BE BE174883A patent/BE851359A/xx not_active IP Right Cessation
- 1977-02-14 JP JP1433777A patent/JPS52100446A/ja active Pending
- 1977-03-07 US US05/776,551 patent/US4147879A/en not_active Expired - Lifetime
- 1977-03-07 US US05/776,555 patent/US4087617A/en not_active Expired - Lifetime
- 1977-03-07 US US05/775,074 patent/US4119664A/en not_active Expired - Lifetime
- 1977-03-07 US US05/776,553 patent/US4119662A/en not_active Expired - Lifetime
- 1977-03-07 US US05/775,075 patent/US4151184A/en not_active Expired - Lifetime
- 1977-03-07 US US05/775,071 patent/US4087618A/en not_active Expired - Lifetime
- 1977-03-07 US US05/776,554 patent/US4118416A/en not_active Expired - Lifetime
-
1978
- 1978-04-28 US US05/901,059 patent/US4156088A/en not_active Expired - Lifetime
- 1978-04-28 US US05/900,840 patent/US4156089A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4087617A (en) | 1978-05-02 |
| US4156088A (en) | 1979-05-22 |
| US4119662A (en) | 1978-10-10 |
| US4151184A (en) | 1979-04-24 |
| US4087618A (en) | 1978-05-02 |
| AU514849B2 (en) | 1981-03-05 |
| BE851359A (ja) | 1977-08-11 |
| US4147879A (en) | 1979-04-03 |
| JPS52100446A (en) | 1977-08-23 |
| US4119664A (en) | 1978-10-10 |
| DE2704933A1 (de) | 1977-08-18 |
| US4156089A (en) | 1979-05-22 |
| US4029681A (en) | 1977-06-14 |
| NL7701467A (nl) | 1977-08-16 |
| AU2133877A (en) | 1978-07-20 |
| CH628028A5 (de) | 1982-02-15 |
| US4118416A (en) | 1978-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA767465B (en) | Prostaglandin analogs | |
| ZA77157B (en) | Prostaglandin analogs | |
| IL51189A0 (en) | Prostaglandin analogs | |
| ZA783065B (en) | Prostaglandin analogs | |
| ZA774419B (en) | Prostaglandin analogs | |
| JPS5384942A (en) | Prostaglandin analogue | |
| GB2079268B (en) | Prostaglandin analogues | |
| ZA767416B (en) | Prostaglandin analogs | |
| ZA767541B (en) | Prostaglandin analogs | |
| GB1538842A (en) | Prostaglandin derivatives | |
| ZA767540B (en) | Prostaglandin analogs | |
| ZA772255B (en) | Prostaglandin analogs | |
| GB1545643A (en) | Prostaglandin derivatives | |
| IL52099A0 (en) | Prostaglandin analogs | |
| AU4019778A (en) | Prostacyclin analogs | |
| HK7482A (en) | Prostaglandin analogues | |
| ZA781608B (en) | Prostaglandin analogs | |
| ZA77160B (en) | Prostaglandin analogs | |
| ZA76512B (en) | Prostaglandin analogs | |
| ZA79962B (en) | Prostaglandin analogs | |
| ZA77159B (en) | Prostaglandin analogs | |
| GB2002355B (en) | Prostaglandin analogues | |
| ZA772820B (en) | Prostaglandin analogs | |
| ZA77158B (en) | Prostaglandin analogs | |
| ZA771725B (en) | Ayal prostaglandin analogs |